StreetAlpha
13F holdings · Q3 2026

Omega Fund Management

Boston, MA · files as Omega Fund Management, LLC
Know the moment Omega Fund Management filesYou follow Omega Fund Management An email or push as soon as its next 13F reaches the SEC, with every stock it bought, sold and trimmed. Next 13F due by Feb 15, 2027
Filed
Holdings as of Sep 30, 2026Filed Nov 16, 2026Next filing due Feb 15, 2027CIK 1637359

Omega Fund Management reported 10 stocks worth $125M in its 13F filing for Q3 2026, filed Nov 16, 2026. Its largest holdings are NUVB (32.0%), BCAX (26.2%) and BBNX (14.6%). Compared with Q2 2026, the fund opened new positions in IMUX, trimmed NUVB, BCAX and BBNX and sold out of ALMS.

Latest filing: what Omega Fund Management did in Q3 2026

vs Q2 2026
Filed 13F-HRView on SEC ↗
1 new0 added4 trimmed1 sold outBought about $4M · sold about $38.5M
New 1
Added 0

None

Trimmed 4
Sold out 1

Dollar changes use the share change at the quarter end price. New and sold out show the whole position.

Reported value$125M−32.6% vs last quarter
Stocks held101 new · 1 sold out
Top 5 weight91.7%very concentrated
Turnover34%of the portfolio changed

Portfolio at a glance

share of reported value · Q3 2026
🔒 A free account shows every holding, what the fund sold and its options.Create free account

Holdings

#StockValueWeightSharesChangeShares, 8 qtrsHeld
1
NUVB
Nuvation Bio Inc
$40M32.0%7.2M−930K (−12%)8 of 8
2
BCAX
Bicara Therapeutics Inc
$32.8M26.2%1.8M−62K (−3%)8 of 8
3
BBNX
Beta Bionics Inc
$18.3M14.6%962K−354K (−27%)7 of 8
4
BBOT
Bridgebio Oncology Therapeut
$13.5M10.8%3.3MNo change5 of 8
5
KMTS
Kestra Med Technologies Ltd
$10.3M8.2%362K−660K (−65%)7 of 8
6
IMUX
Immunic Inc
$4M3.2%430KNew position1 of 8
7
SANA
Sana Biotechnology Inc
$2.5M2.0%844KNo change8 of 8
8
IMA
Imagenebio Inc
$2.1M1.7%455KNo change5 of 8
9
ENGENE HOLDINGS INC
$1.8M1.4%876KNo change8 of 8
10
ODTX
Odyssey Therapeutics, Inc.
$64K0.1%2,893No change2 of 8

Positions at Sep 30, 2026, as reported. Change is against the fund's Q2 2026 filing; weight is the share of the fund's reported stocks.

Sold out

held in Q2 2026, gone in Q3 2026
StockValue last quarterShares sold
ALMS
Alumis Inc
$6.8M241K

Reported value

last 8 quarters
$154MQ4 '24
$169MQ1 '25
$154MQ2 '25
$222MQ3 '25
$287MQ4 '25
$163MQ1 '26
$186MQ2 '26
$125MQ3 '26

The value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.

Filings for Q3 2026

straight from the SEC
FiledFormQuarter
Nov 16, 202613F-HRQ3 2026SEC filing ↗

Other superinvestors

All hedge fund holdings →

Omega Fund Management 13F FAQ

What does Omega Fund Management own?

Omega Fund Management reported 10 stocks worth $125M in its 13F filing for Q3 2026, filed Nov 16, 2026. Its largest holdings are NUVB (32.0%), BCAX (26.2%) and BBNX (14.6%). The table above lists every position in the filing (the top 10 without an account).

What did Omega Fund Management buy and sell in Q3 2026?

Compared with Q2 2026: 1 new positions, 0 added to, 4 trimmed and 1 sold out. New positions include IMUX. It sold all of ALMS.

When will Omega Fund Management file its next 13F?

Holdings as of Dec 31, 2026 are due by Feb 15, 2027. The filing appears on this page within minutes of reaching the SEC.

How much is Omega Fund Management's portfolio worth?

The Q3 2026 filing reports $125M in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.

For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.